L162389 is primarily utilized in the field of pharmaceutical research and development. It is often investigated for its potential therapeutic properties, particularly in the treatment of certain types of cancers. Researchers are exploring its efficacy in inhibiting specific cellular pathways that are crucial for the growth and proliferation of cancer cells. Additionally, L162389 is being studied for its role in modulating immune responses, which could make it a valuable candidate for immunotherapy treatments. Its application extends to preclinical studies where it is used to understand the molecular mechanisms underlying disease progression and to evaluate its safety and effectiveness in animal models.